Cargando…
Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
OBJECTIVES: Candida dubliniensis is an emerging yeast and demonstrated a high adherence property to cystic fibrosis respiratory tract. Therefore, it is important to determine the persistence of C. dubliniensis and to assess the possible relationship to the body mass index (BMI) and forced expiratory...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530559/ https://www.ncbi.nlm.nih.gov/pubmed/28747217 http://dx.doi.org/10.1186/s13104-017-2656-z |
_version_ | 1783253288306606080 |
---|---|
author | AbdulWahab, Atqah Salah, Husam Chandra, Prem Taj-Aldeen, Saad J. |
author_facet | AbdulWahab, Atqah Salah, Husam Chandra, Prem Taj-Aldeen, Saad J. |
author_sort | AbdulWahab, Atqah |
collection | PubMed |
description | OBJECTIVES: Candida dubliniensis is an emerging yeast and demonstrated a high adherence property to cystic fibrosis respiratory tract. Therefore, it is important to determine the persistence of C. dubliniensis and to assess the possible relationship to the body mass index (BMI) and forced expiratory volume in 1st second (FEV1). RESULTS: Candida isolates were identified by MALDI-TOF MS to species level from 40/52 (76.9%) cystic fibrosis patients. C. dubliniensis was the most common organism isolated from 50/77 (65%) lower respiratory specimens of 29 patients. Patients with persistent C. dubliniensis isolates have higher mean BMI in comparison to intermittent C. dubliniensis group. However, this difference did not reach statistical significance (P = 0.539). In contrast, patients with persistent C. dubliniensis isolates have significantly lower FEV1% mean in comparison to intermittent C. dubliniensis group particularly at initial two visits (P < 0.05); however, at subsequent visit the difference observed was not statistically significant (P = 0.456). The persistence of C. dubliniensis is more frequent in adults having more advanced disease, co-infections with chronic P. aeruginosa, cystic fibrosis related diabetes, long-term nebulized tobramycin and oral Zithromax therapy than patients with intermittent C. dubliniensis. Patients with persistent C. dubliniensis have lower FEV1 percentage and higher BMI than the intermittent C. dubliniensis. |
format | Online Article Text |
id | pubmed-5530559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55305592017-08-02 Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis AbdulWahab, Atqah Salah, Husam Chandra, Prem Taj-Aldeen, Saad J. BMC Res Notes Research Note OBJECTIVES: Candida dubliniensis is an emerging yeast and demonstrated a high adherence property to cystic fibrosis respiratory tract. Therefore, it is important to determine the persistence of C. dubliniensis and to assess the possible relationship to the body mass index (BMI) and forced expiratory volume in 1st second (FEV1). RESULTS: Candida isolates were identified by MALDI-TOF MS to species level from 40/52 (76.9%) cystic fibrosis patients. C. dubliniensis was the most common organism isolated from 50/77 (65%) lower respiratory specimens of 29 patients. Patients with persistent C. dubliniensis isolates have higher mean BMI in comparison to intermittent C. dubliniensis group. However, this difference did not reach statistical significance (P = 0.539). In contrast, patients with persistent C. dubliniensis isolates have significantly lower FEV1% mean in comparison to intermittent C. dubliniensis group particularly at initial two visits (P < 0.05); however, at subsequent visit the difference observed was not statistically significant (P = 0.456). The persistence of C. dubliniensis is more frequent in adults having more advanced disease, co-infections with chronic P. aeruginosa, cystic fibrosis related diabetes, long-term nebulized tobramycin and oral Zithromax therapy than patients with intermittent C. dubliniensis. Patients with persistent C. dubliniensis have lower FEV1 percentage and higher BMI than the intermittent C. dubliniensis. BioMed Central 2017-07-26 /pmc/articles/PMC5530559/ /pubmed/28747217 http://dx.doi.org/10.1186/s13104-017-2656-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Note AbdulWahab, Atqah Salah, Husam Chandra, Prem Taj-Aldeen, Saad J. Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis |
title | Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis |
title_full | Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis |
title_fullStr | Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis |
title_full_unstemmed | Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis |
title_short | Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis |
title_sort | persistence of candida dubliniensis and lung function in patients with cystic fibrosis |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530559/ https://www.ncbi.nlm.nih.gov/pubmed/28747217 http://dx.doi.org/10.1186/s13104-017-2656-z |
work_keys_str_mv | AT abdulwahabatqah persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis AT salahhusam persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis AT chandraprem persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis AT tajaldeensaadj persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis |